Industry Voice: BMO's latest engagement - a focus on social issues

Historically difficult for investors to define and quantify, social issues are now among the most pressing issues for companies globally – discover our engagement on some of these issues, including antimicrobial resistance in Q4 2020.

clock • 2 min read

Raising awareness on antimicrobial resistance (AMR)

Engagement progress update

Antimicrobial Resistance (AMR) is a natural phenomenon in which microorganisms develop resistance to antimicrobial agents. However, it is being accelerated by poor stewardship of antibiotics in healthcare and farming: antimicrobial-resistant microbes can spread between people and animals, and from person to person. As a result, a growing number of common bacterial infections - from pneumonia to urinary tract infections - are becoming more difficult to treat. If antibiotics continue to lose their effectiveness, caesarean sections and chemotherapy, as well as other commonplace medical interventions, could become extremely high risk and severely undermine modern medicine.

 

Continue Reading

 

Disclaimers:

The value of investments and any income derived from them can go down as well as up as a result of market or currency movements and investors may not get back the original amount invested. Views and opinions have been arrived at by BMO Global Asset Management and should not be considered to be a recommendation or solicitation to buy or sell any stocks or products that may be mentioned.  

©2021 BMO Global Asset Management. BMO Global Asset Management is a registered trading name for various affiliated entities of BMO Global Asset Management (EMEA) that provide investment management services, institutional client services and securities products. Financial promotions are issued for marketing and information purposes; in the United Kingdom by BMO Asset Management Limited, which is authorised and regulated by the Financial Conduct Authority; in the EU by BMO Asset Management Netherlands B.V., which is regulated by the Dutch Authority for the Financial Markets (AFM); and in Switzerland by BMO Global Asset Management (Swiss) GmbH, acting as representative office of BMO Asset Management Limited. These entities are all wholly owned subsidiaries of Columbia Threadneedle Investments UK International Limited, whose direct parent is Ameriprise Inc., a company incorporated in the United States. They were formerly part of BMO Financial Group and are currently using the "BMO" mark under licence.

More on ESG

Earth Day 2024: Decarbonisation megatrend boosts prospects for European industrials
ESG

Earth Day 2024: Decarbonisation megatrend boosts prospects for European industrials

Cautious on investing in wind energy

Matthew Donen
clock 19 April 2024 • 4 min read
Holtara's Cristian Echavarria: A sustainable fund by any other name
ESG

Holtara's Cristian Echavarria: A sustainable fund by any other name

Likely outcomes of the consultation

Cristian Echavarria
clock 16 April 2024 • 4 min read
'Tinkering around the edges': The green economy reacts to Spring Budget 2024
ESG

'Tinkering around the edges': The green economy reacts to Spring Budget 2024

BusinessGreen rounds up

BusinessGreen staff
clock 06 March 2024 • 10 min read
Trustpilot